CSF3 and heart failure: The mean life expectancy, calculated by the Seattle Heart Failure Model at 10-year follow-up, was significantly higher for G-CSF patients compared to control patients (15 ± 4 years vs. 12 ± 4 years, p = 0.046, respectively) (Figure 4B).